Skip to content
lifestyle.ukuncut.org.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aligos Therapeutics
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
November 6, 2026
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026
November 5, 2026
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
October 5, 2026
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
September 2, 2026
Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China
August 12, 2026
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
August 6, 2026
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
May 27, 2026
Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
May 13, 2026